There is no good data because it's a sucky scale -- which is why the papers you will find are more concerned about other prognostic markers, on which there is no consensus as yet.
It's a real issue because clinical trials suffer from not knowing if pts are going to make it through the trial, and what their "normal" rate of progression would be w/o the intervention under test.
Modern datasets will generally support an "average" monthly FRS drop of 1-3 points, but that is not evenly distributed. The better studies suggest that progression is fastest in the beginning and the end, and slower in the middle, FRS-wise.
So if the score dropped more in a given interval than it had before, that might -- might -- suggest that you were coming out of the middle. But your own eyes are the best judge with breathing and nutrition the two must-haves. And as I have said before, proactive BiPAP management (adjusting settings as conditions warrant) can mediate breathing decline longer than some people think.
There are also papers purporting to show patterns of progression, but they're not very good either.
Sorry to be so unhelpful.
Best,
Laurie